comparemela.com

Latest Breaking News On - Amy dezern - Page 1 : comparemela.com

Retrospective Claims Data and Patient Reported-Outcomes from COMMANDS Trial in Lower-Risk MDS

Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS trial.

Amy dezernEvolving treatment landscapeMyelodysplastic syndromesClaims dataPatient reported outcomesMds treatmentMyelodysplastic syndromes treatmentMash 2023Real world outcomesCommands trialCommands studyHealthcare claimsHealthcare claims database

First-Line Treatment of Lower-Risk MDS with Symptomatic Anemia

Amy DeZern, MD, MHS, provides clinical insights on the first-line treatment of patients with lower-risk MDS and symptomatic anemia.

Amy dezernEvolving treatment landscapeMyelodysplastic syndromesLine treatmentFirst line treatmentFirst line therapiesSymptomatic anemiaMds treatmentMyelodysplastic syndromes treatment

vimarsana © 2020. All Rights Reserved.